Workflow
BAT(BTI)
icon
Search documents
British American Tobacco: Shares Still A Bargain After The Mid-Year Rally
Seeking Alpha· 2024-09-17 12:23
Core Insights - The article emphasizes the importance of creating engaging and educational financial content for various audiences, particularly focusing on thematic investing and market events [1] Group 1: Content Creation - The company specializes in producing written content in multiple formats, including articles, blogs, and social media, aimed at financial advisors and investment firms [1] - There is a strong focus on making financial data accessible and relevant, utilizing a narrative approach to engage everyday investors [1] Group 2: Analytical Approach - The company analyzes stock market sectors, ETFs, economic data, and broad market conditions to identify investment opportunities [1] - Macro drivers of various asset classes such as stocks, bonds, commodities, currencies, and crypto are highlighted as key areas of interest [1] Group 3: Communication Style - The communication style is described as educational and creative, with an emphasis on evidence-based narratives supported by empirical data [1] - Visual tools like charts are utilized to simplify complex financial stories and enhance engagement [1]
Should You Invest in British American Tobacco (BTI) Based on Bullish Wall Street Views?
ZACKS· 2024-09-12 14:31
Group 1: Brokerage Recommendations - British American Tobacco (BTI) has an average brokerage recommendation (ABR) of 1.93, indicating a position between Strong Buy and Buy, based on recommendations from seven brokerage firms [2] - Of the seven recommendations, three are Strong Buy and one is Buy, accounting for 42.9% and 14.3% of all recommendations respectively [2] - Despite the positive ABR, relying solely on brokerage recommendations may not be advisable, as studies show they often fail to guide investors effectively towards stocks with high price appreciation potential [3][4] Group 2: Analyst Bias and Zacks Rank - Analysts from brokerage firms tend to exhibit a positive bias in their ratings due to vested interests, leading to a disproportionate number of favorable recommendations compared to negative ones [4][8] - The Zacks Rank, a proprietary stock rating tool, categorizes stocks based on earnings estimate revisions and is considered a more reliable indicator of near-term price performance compared to ABR [6][9] - The Zacks Rank is updated more frequently than ABR, reflecting timely changes in earnings estimates, which are crucial for predicting future price movements [10] Group 3: Earnings Estimates and Investment Potential - The Zacks Consensus Estimate for British American Tobacco has increased by 0.2% over the past month to $4.70, indicating growing analyst optimism regarding the company's earnings prospects [11] - This increase in consensus estimates, along with other factors, has resulted in a Zacks Rank of 2 (Buy) for British American Tobacco, suggesting potential for stock appreciation [12]
Dividend Harvesting Portfolio Week 184: $18,400 Allocated, $1,706.01 In Projected Dividends
Seeking Alpha· 2024-09-12 13:30
Core Insights - The Dividend Harvesting Portfolio experienced a -2% decline in value, marking the second decrease in 12 weeks, amidst market volatility due to upcoming CPI reports, a Federal Reserve meeting, and an election cycle [1][2] - Despite the decline, the portfolio remains profitable with a total account balance of $22,182.22, reflecting a 20.56% return on invested capital [1][2] - The portfolio generated $46.89 in dividend income for the week, increasing the projected annualized dividend income to $1,706.01, with expectations to exceed $1,850 by year-end [1][4] Portfolio Performance - The S&P 500 and Nasdaq indices declined by -3.51% and -4.64% respectively during the same week, indicating a challenging market environment [2] - The portfolio's strategy focuses on long-term growth and income generation, with a diversified approach to mitigate downside risk [2][17] - The portfolio's composition includes 39.27% in individual equities, generating 27.20% of dividend income, while REITs, CEFs, and BDCs account for 60.73% of the portfolio and generate 72.80% of forward income [9] Dividend Income Breakdown - The portfolio's dividend income is distributed across various investment categories: Equities ($463.98), ETFs ($452.96), CEFs ($299.19), REITs ($291.02), and BDCs ($198.86) [3] - Year-to-date dividend income for 2024 has reached $1,032.53 from 486 dividends, surpassing 105.78% of the total dividend income generated in 2023 [3] Future Outlook - Anticipation of rate cuts is expected to positively impact the portfolio, particularly in sectors like REITs, CEFs, and BDCs [8][15] - The addition of Ford to the portfolio is seen as a strategic move, with expectations for increased car sales and improved margins due to potential refinancing opportunities [14] - The portfolio aims to achieve a more balanced sector allocation over the long term, although this may take several years to realize [9][17]
Buy These 6 Ultra High Yielding Dividend Aristocrats Before It's Too Late
Seeking Alpha· 2024-09-07 11:00
Group 1 - Market volatility has returned, highlighted by Nvidia's (NVDA) 9.5% plunge in a single day, resulting in a $280 billion loss in market capitalization, equivalent to Chevron's (CVX) entire value [1] - Big tech companies are currently facing significant challenges, while high-yield aristocrats are thriving, reminiscent of the tech crash when high-yield value stocks surged [1][2] - The current market environment is not a tech bubble, as the mega-cap companies are backed by substantial cash reserves, with $1.2 trillion on their balance sheets [3][4] Group 2 - High-yield aristocrats like Realty Income (O), Enterprise Products (EPD), and British American Tobacco (BTI) are trading at historically low valuations, presenting potential investment opportunities [2][24] - The expected earnings growth for big tech is projected at 23% for the next year, indicating that these companies are not in a bubble despite current market conditions [8][9] - The bond market is pricing in potential rate cuts, which could indirectly benefit high-yield aristocrats by stimulating consumer spending and improving economic conditions [12][15] Group 3 - The analysis indicates that ultra-yield aristocrats are currently undervalued, with an average yield of 6.7%, significantly higher than the S&P's yield [33][36] - Historical performance shows that these aristocrats have delivered better volatility-adjusted returns compared to the S&P, with a lower risk profile [38][41] - The consensus return potential for these aristocrats is projected at 56% over the next few years, suggesting strong growth prospects if they return to historical fair value [46][47]
These Ultra-High Dividend Stocks Are Soaring: Is It Too Late to Buy Shares?
The Motley Fool· 2024-09-05 10:15
Core Viewpoint - Investors are shifting focus to high-yield stocks as the Federal Reserve signals a decline in interest rates, benefiting companies like Altria Group and British American Tobacco [1][11]. Altria Group - Altria Group offers a 7.29% dividend yield, down from over 9% earlier this year, and owns the leading premium cigarette brand, Marlboro, along with other nicotine products [3][12]. - Despite a decline in Marlboro shipment volumes by over 10% this year, Altria's operating income has increased by 51.8% over the last decade due to its pricing power [4][6]. - The company has a share repurchase program that has reduced shares outstanding by 13.7% in the last 10 years, supporting dividend growth [6]. - Altria is diversifying its revenue streams through cigars, vaping, and nicotine pouches, which are expected to offset declines in traditional cigarette volumes [5][12]. British American Tobacco - British American Tobacco has a higher dividend yield of 7.8% and faces similar challenges in the U.S. market, needing to raise prices to maintain profits [7][8]. - The company benefits from international market exposure, which is experiencing slower volume declines compared to the U.S., although it faces foreign currency risks [9]. - British American Tobacco is performing well in the new tobacco-free nicotine product segment, with smokeless products accounting for 16.5% of revenue in fiscal 2023 and achieving positive profitability [10]. - The company is well-positioned to maintain or grow its dividend due to cash-flow growth from its expanding product lines [10][12]. Investment Considerations - Both Altria and British American Tobacco offer dividend yields significantly higher than traditional savings accounts, making them attractive to income-focused investors, especially with anticipated declines in Treasury rates [11]. - The sustainability of their dividend yields is supported by their ability to counteract volume declines through price increases and contributions from new product divisions [12][13]. - There is potential for consistent growth in dividend-per-share payouts over the next five to ten years, appealing to long-term investors [13].
Is British American Tobacco (BTI) Outperforming Other Consumer Staples Stocks This Year?
ZACKS· 2024-09-03 14:40
Company Overview - British American Tobacco (BTI) is part of the Consumer Staples sector, which includes 183 companies and is currently ranked 13 in the Zacks Sector Rank [2] - BTI has a Zacks Rank of 2 (Buy), indicating a favorable outlook based on earnings estimates and revisions [3] Performance Analysis - BTI has gained approximately 28.3% year-to-date, significantly outperforming the average return of 8.2% for the Consumer Staples sector [4] - In comparison, another Consumer Staples stock, Wolters Kluwer NV (WTKWY), has returned 19% year-to-date [4] Industry Context - BTI is categorized under the Tobacco industry, which consists of 6 companies and is currently ranked 21 in the Zacks Industry Rank [5] - The Tobacco industry has an average year-to-date gain of 33.4%, indicating that BTI is slightly underperforming its industry peers [5] - Wolters Kluwer NV belongs to the Publishing - Books industry, which has gained 33.5% this year and is ranked 194 [6] Future Outlook - Investors are encouraged to monitor both British American Tobacco and Wolters Kluwer NV for potential continued strong performance in the Consumer Staples sector [6]
Prediction: These 2 Dividend-Paying Stocks Will Outperform the Market This Decade
The Motley Fool· 2024-08-24 07:39
Core Viewpoint - Investors are undervaluing high-yielding stocks, particularly those with strong dividend growth potential, amidst a market driven by the AI narrative and high valuations [1][2]. Group 1: Philip Morris International - Philip Morris International, a major global tobacco company, has shown strong earnings growth from its legacy brands due to stable cigarette usage in Europe and price increases [3][5]. - The company has diversified into the new-age nicotine market with products like Iqos and Zyn, attracting 36.5 million customers [4]. - Projected total shipment volumes for 2024 are expected to grow by 1% to 2%, with earnings per share (EPS) anticipated to increase by 11% to 13% [5]. - The stock currently offers a dividend yield of 4.4%, significantly higher than the S&P 500 average of 1.3%, with potential for consistent dividend growth over the next five to ten years [6]. Group 2: British American Tobacco - British American Tobacco has a high dividend yield of 8.1%, nearly double that of Philip Morris, but faces challenges with a 12.5% year-over-year decline in combustibles volume in the first half of 2024 [7][8]. - Despite volume declines, the company has managed to grow free cash flow per share to $5.30 over the last 12 months [8]. - The "new categories" segment, including oral nicotine pouches and vapor devices, is projected to reach around $5 billion in annual revenue and has recently achieved positive profitability [9]. - The company is expected to continue growing free cash flow per share over the next five to ten years, even with ongoing declines in the cigarette business [10][11].
British American Tobacco: Called The Surge, Staying Invested
Seeking Alpha· 2024-08-24 07:36
Core Viewpoint - British American Tobacco (BTI) has shown strong performance relative to the S&P 500, but fundamental challenges in the tobacco industry raise questions about the sustainability of this performance [1][2][27] Recent Performance - BTI has outperformed the SPY ETF since the beginning of the year, but its performance is in line with peers, indicating broader industry trends [2] - Year-over-year revenue growth has declined for BTI and its peers, including Altria and Imperial Brands, highlighting systematic headwinds in the tobacco sector [3][4] Financial Performance - BTI reported an 8.2% year-over-year decrease in half-year revenue, primarily due to the divestiture of its Russian and Belarus segments, with core revenue declining only 0.2% [5] - The company's organic revenue was impacted by pricing challenges, which are seen as a broader economic issue rather than specific to BTI [6] - BTI's operating profit margin was 34.5% in H1, indicating robust profitability despite challenges [11] Segment Performance - The "new categories" segment now accounts for approximately 17.9% of BTI's revenue mix, showing strong year-over-year growth and potential for future expansion [9] - Combustible product sales struggled in H1, with volumes remaining stable but pricing pressures affecting revenue [8] Investment and Valuation - BTI's forward dividend yield is around 8.18%, higher than its peers, and the company has a history of consistent dividend payments [23][24] - A peer-based analysis shows BTI's valuation metrics are low, with a forward price-to-earnings-growth ratio of 1.89x, indicating compelling bottom-line value [19][20] Future Outlook - BTI plans to increase its stake in a Canadian cannabis producer, which could provide diversification and growth opportunities [10] - The company is expected to maintain a low debt-to-EBITDA ratio, allowing for potential reinvestment in new product categories [15]
Wall Street Analysts Look Bullish on British American Tobacco (BTI): Should You Buy?
ZACKS· 2024-08-20 14:31
Core Viewpoint - Analyst recommendations play a significant role in influencing stock prices, but their reliability is questionable, particularly for British American Tobacco (BTI) [1][3]. Brokerage Recommendation Summary - British American Tobacco has an average brokerage recommendation (ABR) of 1.94, indicating a position between Strong Buy and Buy, based on recommendations from nine brokerage firms [2]. - Among the nine recommendations, four are classified as Strong Buy (44.4%) and one as Buy (11.1%) [2]. Analyst Bias and Reliability - Brokerage analysts often exhibit a positive bias due to vested interests, leading to a disproportionate number of favorable ratings compared to negative ones [4][8]. - Studies suggest that brokerage recommendations may not effectively guide investors toward stocks with the highest potential for price appreciation [3][8]. Zacks Rank vs. ABR - The Zacks Rank, which is based on earnings estimate revisions, is a more reliable indicator of a stock's near-term price performance compared to ABR [6][9]. - The Zacks Rank is updated more frequently and reflects changes in earnings estimates, making it a timely tool for predicting future price movements [10]. Earnings Estimate Insights - The Zacks Consensus Estimate for British American Tobacco has increased by 0.6% over the past month to $4.69, indicating growing analyst optimism regarding the company's earnings prospects [11]. - The recent change in consensus estimates, along with other factors, has resulted in a Zacks Rank of 2 (Buy) for British American Tobacco, suggesting a positive outlook for the stock [12].
I Am Locking In 2 Fat +7% Yields As Interest Rates Fall
Seeking Alpha· 2024-08-17 14:30
Investment Insights - The article discusses two investment picks: Healthcare Realty Trust (HR) and British American Tobacco (BAT), highlighting their strong dividend yields and growth potential [4][11]. Healthcare Realty Trust (HR) - HR is a Real Estate Investment Trust (REIT) focused on medical office buildings, owning 673 properties primarily near leading hospital campuses [4]. - For Q2 2024, HR reported FFO/share of $0.38, covering its $0.31/share quarterly dividend, with NOI growth exceeding expectations [4][8]. - The REIT projects year-over-year NOI growth of 4.5% to 5.5% in the second half of 2024 [4]. - Strong leasing activity was noted, with over 400,000 sq ft of new leases signed for the fourth consecutive quarter, and a record new lease pipeline of 1.9 million sq ft [5]. - HR's occupancy rate improved to 85.5% from 79.3% year-over-year, with projections to reach 87% in the second half of 2024 [6]. - NOI growth was reported at 3.5% YoY in Q2, with total multi-tenant NOI growing 3.9% YoY, both at the high end of guidance [7]. - The dividend is now fully covered, with a projected normalized FFO of $1.53 to $1.55/share for FY 2024, resulting in a 79% payout ratio [8]. - HR's joint venture with KKR & Co. has generated $400 million in proceeds year-to-date, with expectations of over $1 billion for the full year [9]. - The company ended Q2 with a leverage ratio of 6.4x and plans to reduce leverage further by FY 2024 [10]. British American Tobacco (BAT) - BAT is the largest global tobacco company, with a current yield of 8.2% and stock trading approximately 24% above its recent low [11][18]. - The company reported 1.4 million new smokeless product consumers in 1H 2024, totaling 26.4 million, with new category revenue reaching £1.7 billion, representing 17.9% of group revenue [13]. - BAT's e-cigarette brand Vuse holds a 40.9% market share in leading markets, with smokeless products constituting 20% of total U.S. revenues in 1H 2024 [15]. - Despite lower combustible revenues in the U.S., BAT's strong growth in other regions has cushioned the impact [16]. - The company maintains a strong liquidity position with an average debt maturity of 9.2 years and a fixed debt profile of 84% [17]. - BAT has initiated a share repurchase program, planning to buy back £700 million worth of shares in 2024 and £900 million in 2025 [18]. - The tobacco industry is characterized by its ability to pass on higher prices to consumers, ensuring resilience against economic pressures [18]. Conclusion - HR is positioned to benefit from the growing demand for healthcare and limited supply of medical office buildings, while BAT is adapting to a smokeless future, both providing solid dividend sources for investors [19].